Doctor Huihua Li

Pfizer Inc., New York (United States of America)

Follow

Contributor content

Estimating treatment effect of tafamidis on hospitalisation in NYHA class III ATTR-CM patients in the presence of death using principal stratification

Presentation

Estimating treatment effect of tafamidis on hospitalisation in NYHA class III ATTR-CM patients in the presence of death using principal stratification

ESC 365 is supported by

novartis

Explore sponsored resources